ATC Classification
 | A – ALIMENTARY TRACT AND METABOLISM | |||||
| A02 – DRUGS FOR ACID RELATED DISORDERS | |||||
| A02A – ANTACIDS | |||||
 | Gefal, suspension 230,0 g (Gefalum) | |||||
| A02B – DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) | |||||
| Bien (capsules 0,1 g, 0,2 g, 0,4 g) (Capsulae Bieni 0,1, 0,2 et 0,4)) | |||||
| FAMO, coated tablets 20 mg (Famo (tablets)) | |||||
| A03 – DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | |||||
| A03A – DRUGS FOR FUNCTIONALGASTROINTESTINAL DISORDERS | |||||
| Drotaverine hydrochloride, solution for injections 20 mg-ml (Solutio Drotaverini hydrochloride 2% pro injectionibus) | |||||
| Drotaverine hydrochloride, tablets 40 mg (Tabulettae Drotaverini hydrochloridi 0,04) | |||||
| A03B – BELLADONNA AND DERIVATIVES, PLAIN | |||||
| Atropine-Belmed, solution for injections 1mg/ml (Solutio Atropini sulfatis 0,1 % pro injectionibus) | |||||
| A04 – ANTIEMETICS AND ANTINAUSEANTS | |||||
| A04A - ANTIEMETICS AND ANTINAUSEANTS | |||||
| Tropisetron, capsules 5 mg (Tropisetron) | |||||
| Tropisetron, solution for injection 1 mg/ml (Tropisetron) | |||||
| A05 – BILE AND LIVER THERAPY | |||||
| A05A – BILE THERAPY | |||||
| Allochol,coated tablets (Allocholum) | |||||
| A05B – LIVER THERAPY, LIPOTROPICS | |||||
| Bienosilim, capsules (Bienocilim) | |||||
| A06 DRUGS FOR CONSTIPATION | |||||
| A06A DRUGS FOR CONSTIPATION | |||||
| A07 – ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS | |||||
| A07A- INTESTINAL ANTIINFECTIVES | |||||
| Nystatin, coated tablets 500000 IU (Nystatinum (coated tablets, 500000 UNITS)) | |||||
| A07C – ELECTROLYTES WITH CARBOHYDRATES | |||||
| A07F – ANTIDIARRHEAL MICROORGANISMS | |||||
| A09 – DIGESTIVES, INCLUDING ENZYMES | |||||
| A09A – DIGESTIVES, INCLUDING ENZYMES | |||||
| Acidin-Pepsin tablets (Acidin-Pepsinum) | |||||
| Pancreatin coated tablets 25 IU (Pancreatinum) | |||||
| A10 – DRUGS USED IN DIABETES | |||||
| A10A – INSULINS AND ANALOGUES | |||||
| Insulin-long SMC suspension for injection 100 unitsml (Insulinum-longum SMC) | |||||
| Insulin-semilong SMC suspension for injection 100 unitsml (Insulinum-semilongum SMC) | |||||
| Protamin-insulin HS, suspension for injections 100 IU-ml - 10 ml in vial (Protamin-insulinum HS) | |||||
| A10B – BLOOD GLUCOSE LOWERING DRUGS, EXCLUDING INSULINS | |||||
| Glibenclamide, tablets 5 mg № 50 (Tabulettae Glibenclamidi 0.005) | |||||
| A11 – VITAMINS | |||||
| A11B – MULTIVITAMINS, PLAIN | |||||
| A11C – VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO | |||||
| Retinoli acetat, oily solution in capsules 33000 IU (Solutio Retinoli palmitatis oleosa in capsulis (Vitaminum A) 100000 МЕ) | |||||
| Retinoli acetat, oily solution in capsules 5000 IU (Solutio Retinoli palmitatis oleosa in capsulis (Vitaminum A) 100000 МЕ) | |||||
| A11G – ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS | |||||
| A11H – OTHER PLAIN VITAMIN PREPARATIONS | |||||
| Alpha-tocopherol acetate, capsules 100 mg (Solutio - Tocopheroli acetatis (Vitamini E) oleosa) | |||||
| A11J – OTHER VITAMIN PRODUCTS, COMBINATIONS | |||||
| Aevit, capsules (Ayevit) | |||||
| A12 – MINERAL SUPPLEMENTS | |||||
| A12C – OTHER MINERAL SUPPLEMENTS | |||||
| Selenobel, tablets 0,4 mg (Tabulettae "Selenobel" 0,4) | |||||
| A13 – TONICS | |||||
| A13A – TONICS | |||||
| Echingin, tablets (Tabulettae "Echingin") | |||||
| Mildrocard, capsules 250 mg (Meldonium) | |||||
| Phytonsol, tablets (Tabulettae "Phytonsol") | |||||
| Trimunal, tablets № 20 (Tabulettae "Trimunal") | |||||
| A14 – ANATOMIC AGENTS FOR SYSTEMIC USE | |||||
| A14B – OTHER ANABOLIC AGENTS | |||||
| A16 – OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS | |||||
| A16A – OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS | |||||
| Carnitini chloridi, solution for injection 10% - 5% (Solutio Carnitini chloridi 10% pro injectionibus) | |||||
| B – BLOOD AND BLOOD FORMING ORGANS | |||||
| B01 – ANTITHROMBOTIC AGENTS | |||||
| B01A – ANTITHROMBOTIC AGENTS | |||||
| Clopidogrel, coated tablets 75 mg ( Clopidogrel) | |||||
| Heparin, gel 1000 IU-1,0 g, 30 g (Gelum Heparini) | |||||
| Heparin, solution for injection 5000 IU-1ml- 5ml (Solutio Heparini pro injectionibus 5000 ED/ml) | |||||
| Ovomine, solution for injections 5 ml (Ovominum) | |||||
| Streptokinase 1500000 IU in vial (lyophilizated powder for preparation of solution for injection) | |||||
| Streptokinase750000 IU in vial (Streptokinase lyophilizated powder for preparation of solution for injection 750000 U) | |||||
| B02 - ANTIHEMORRHAGICS | |||||
| B02B- VITAMIN K AND OTHER HEMOSTATICS | |||||
| B03 – ANTIANEMIC PREPARATIONS | |||||
| B03A IRON PREPARATIONS | |||||
| Ferronal, coated tablets 300 mg (Ferronal (tablets)) | |||||
| Speisferron, solution for injections (Speisferron) | |||||
| B03X – OTHER ANTIANEMIC PREPARATIONS | |||||
| B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS | |||||
| B05A BLOOD AND RELATED PRODUCTS | |||||
| Polyglicin, solution for infusion 400 ml in bottle № 1 (Рolyglucinum) | |||||
| Reopolyglucin, solution for infusion 200 ml bottle (Rheopolyglucinum cum glucoso) | |||||
| Reopolyglucin, solution for infusion 400 ml bottle (Rheopolyglucinum cum glucoso) | |||||
| Rheogluman, solution for infusion 400 ml (Rheoglumanum) | |||||
| B05B – I.V. SOLUTIONS | |||||
| Acesol, solution for infusions (Acesolum) | |||||
| Asparkam-L, solution for infusion (Solutio pro infusionibus "Asparkam-L") | |||||
| Asparkam-L, solution for injection (Solutio pro injeсtionibus "Asparkam-L") | |||||
| Mannit, solution for infusion 15 %- 400 ml in bottle (Solutio Manniti 15% pro infusia) | |||||
| Quintasol, solution for infusions (Quintasolum) | |||||
| Sormantol, solution for infusion 400 ml (Solutio Sormantoli) | |||||
| B05C – IRRIGATING SOLUTIONS | |||||
| B05X – I.V. SOLUTION ADDITIVES | |||||
| B06 – OTHER HEMATOLOGICAL AGENTS | |||||
| B06A – OTHER HEMATOLOGICAL AGENTS | |||||
| Lidasa, powder for injection 64 IU in vials №5 (Lydazum) | |||||
| C – CARDIOVASCULAR SYSTEM | |||||
| C01 – CARDIAC THERAPY | |||||
| C01B - ANTIARRHYTHICS, CLASS 1 AND 3 | |||||
| Acetylsalicylic acid, lyophilized powder for solution for injections 50 mg (Acidum acetylsalicylicum 0,25 et 0,05) | |||||
| Novocainamid, solution for injections 10 %- 5 ml № 5 (Solution Novocainamidi 10% pro injectionibus) | |||||
| C01D – VASODILATORS USED IN CARDIAC DISEASES | |||||
| Monolong, capsules 40 mg (Monolong (capsules of durable action 0.04)) | |||||
| C01E – OTHER CARDIAC PREPARATIONS | |||||
| Mildrocard, solution for intravenous and intramuscular injection 100 mg/ml (Meldonium) | |||||
| Riboxin, film-coated tablets 200 mg (Inosine) | |||||
| Validole, capsules 100 mg (Capsulae Validoli 0.1 g) | |||||
| C02 - ANTIHYPERTENSIVES | |||||
| C02A - ANTIADRENERGIC AGENTS, CENTRALLY ACTING | |||||
| Clophelin, tablets 0,15 mg (Tabulettae Clophelini 0,000075 et 0,00015) | |||||
| Moxonidine, coated tablets 0.2 mg; 0.3 mg; 0.4 mg (Moxonidine) | |||||
| C03 – DIURETICS | |||||
| C03B – LOW-CEILING DIURETICS, EXCL. THIAZIDES | |||||
| Pamid, coated tablets 2,5 mg № 30 (Pamid) | |||||
| C03C – HIGH-CEILING DIURETICS | |||||
| Furosemide, tablets 40 mg (Furosemide) | |||||
| C05 – VASOPROTECTIVES | |||||
| C05B – ANTIVARICOSE THERAPY | |||||
| C05C – CAPILLARY STABILIZING AGENTS | |||||
| Rutascorbin, tablets № 50 (Rutascorbin) | |||||
| C07 – BETA BLOCKING AGENTS | |||||
| C07A – BETA BLOCKING AGENTS | |||||
| Betaxolol, tablets 20 mg (Betaxolol) | |||||
| C08 – CALCIUM CHANNEL BLOCKERS | |||||
| C08C – SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS | |||||
| Amlodipine, tablets 5 mg, 10 mg (Amlodipine) | |||||
| C08D - SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS | |||||
| Verapamil hydrochloride, coated tablets (Tabulettae Verapamili hydrochloridi 0.04 et 0.08 obductae) | |||||
| C09 – AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM | |||||
| C09A – ACE INHIBITORS, PLAIN | |||||
| Enalapril, tablets 10 mg (Enalapril) | |||||
| C09B – ACE INHIBITORS, COMBINATIONS | |||||
| Paralel, tablets 5mg/10mg (Amlodipine + Lisinopril) | |||||
| C09C – ANGIOTENSIN 2 ANTAGONISTS, PLAIN | |||||
| Losartan, film-coated tablets 50 mg, 100 mg (Losartan) | |||||
| C10 – LIPID MODIFYING AGENTS | |||||
| C10A - LIPID MODIFYING AGENTS, PLAIN | |||||
| Antisclerol, capsules 300 mg (Antisclerol) | |||||
| Atorvastatin, film-coated tablets 10mg, 20mg (Atorvastatin) | |||||
| C10B – LIPID MODIFYING AGENTS, COMBINATIONS | |||||
| Statinam, film-coated tablets 5mg/10mg, 10mg/10mg (Amlodipine + Atorvastatin) | |||||
| D – DERMATOLOGICALS | |||||
| D01 – ANTIFUNGALS FOR DERMATOLOGICAL USE | |||||
| D01A – ANTIFUNGALS FOR TOPICAL USE | |||||
| Nystatin, ointment 100 000 IU-1,0 g - 25 g (Unguentum Nistatini 1000000 ED/g) | |||||
| Terbinafine cream 1 % - 15,0 g (Сreme Terbinafini 1%) | |||||
| D01B – ANTIFUNGALS FOR SYSTEMIC USE | |||||
| D02 – EMOLLIENTS AND PROTECTIVES | |||||
| D02B – PROTECTIVES AGAINST UV – RADIATION | |||||
| Melanin, (Melanin 0,5 mg + Bien 50 mg) ointment 0,005% - 15,0 g (Unguentum Melanini 0,05%) | |||||
| D03 – PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS | |||||
| D03A – CICATRIZANTS | |||||
| Reparaef-1, ointment 15 g (Unguentum Reparaef-1) | |||||
| Reparaef-2, ointment 15 g (Unguentum Reparaef-2) | |||||
| Vitreous body, solution for injections (Corpus vitreum) | |||||
| D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE | |||||
| D06A – ANTIBIOTICS FOR TOPICAL USE | |||||
| Gentamicin, hydrogel plate 1mg.g (Hydrogelum Gentamycini 0.1%) | |||||
| Gentamicin, ointment 0,1%-25,0g (Unguentum Gentamycini 0.1%) | |||||
| D06B – CHEMOTHERAPEUTICS FOR TOPICAL USE | |||||
| Aciclovir, ointment 50mg/g (Unguentum Acicloviri 5 %) | |||||
| Nucleavir, ointment 5% - 5,0 g (Unguentum "Nucleavir") | |||||
| Oxolin, ointment 0,25% 15 g (Unguentum Oxolini 0,25%) | |||||
| D07 – CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS | |||||
| D07A – CORTICOSTEROIDS, PLAIN | |||||
| Hydrocortisone, ointment 1%- 10,0 g (Unguentum Нydrocortisoni 1%) | |||||
| Prednisolon, ointment 0,5% - 10 g (Unguentum Prednisoloni 0,5%) | |||||
| D08 – ANTISEPTICS AND DISINFECTANTS | |||||
| D08A – ANTISEPTICS AND DISINFECTANTS | |||||
| Septomirin, solution 0,01% 100 ml (Myramistinum) | |||||
| Viridis nitensis, alcohol solution 10mg.ml (Solutio Viridis nitentis spirituosa 1 % et 2 %) | |||||
| D11 – OTHER DERMATOLOGICAL PREPARATIONS | |||||
| D11A – OTHER DERMATOLOGICAL PREPARATIONS | |||||
| Dermaraef, ointment 15,0 g (Unguentum Dermaraef) | |||||
| G – GENITO URINARY SYSTEM AND SEX HORMONES | |||||
| G02 – OTHER GINECOLOGICALS | |||||
| G02C – OTHER GINECOLOGICALS | |||||
| G04 – UROLOGICALS | |||||
| G04B – UROLOGICALS | |||||
| Casolin, capsules 200 mg (Capsulae Casolini 0,2) | |||||
| Novitropan, tablets 5 mg № 20 (Novitropan (tablets 0.25 g)) | |||||
| Potentsagra, capsules 50 mg (Capsulae "Potentsagra" 0,025 et 0,05) | |||||
| Predsatine, lyophilized powder for solution for injections 5 mg (Predstatinum) | |||||
| H – SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | |||||
| H02 – CORTICOSTEROIDS FOR SYSTEMIC USE | |||||
| H02A – CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN | |||||
| Dexamethasone, solution for injection 0,4%- 1ml (Dexamethasone solutio pro injeсtionibus) | |||||
| Dexamethasone, solution for injection 0,4%- 2 ml (Dexamethasone solutio pro injeсtionibus) | |||||
| Prednisolon, tablets 5 mg № 50 g (Tabuletae Prednisoloni 0,005) | |||||
| H03 – THYROID THERAPY | |||||
| H03A – THEROID PREPARATIONS | |||||
| Levothyroxine sodium, 0,1 mg (Levothyroxine sodium 0.0001 g) | |||||
| J – ANTIINFECTIVES FOR SYSTEMIC USE | |||||
| J01 – ANTIBACTERIALS FOR SYSTEMIC USE | |||||
| J01A – TETRACYCLINES | |||||
| Doxycycline hydrochloride, capsules 100 mg (Capsulae Doxycyclini hydrochloride 0.1) | |||||
| Tetracycline, coated tablets 100 mg № 20 (Tabulettae Tetracyclini 0,1 obductae) | |||||
| Tetracycline, coated tablets 100 mg №10 (Tabulettae Tetracyclini 0,1 obductae) | |||||
| J01B – AMPHENICOLS | |||||
| Levomycetin, capsules 250 mg (Capsulae Laevomycetini 0,25) | |||||
| J01C - BETA – LACTAM ANTIBACTERIALS, PENICILLINS | |||||
| Amklav, coated tablets 250 mg/125 mg (Amoxicillin and enzyme inhibitor) | |||||
| Amoxicillin, capsules 250 mg (Amoxicillin) | |||||
| Ampicillin trihydrate,tablets 250 mg (Tabulettae Ampicillini trihydratis 0,25) | |||||
| J01D – OTHER BETA-LACTAM ANTIBACTERIALS | |||||
| Cefalexin, capsules 250 mg (Cefalexin) | |||||
| Cefazolin, powder for solution for intravenous and intramuscular injection 500 mg and 1000 mg (Cefazolin) | |||||
| Cefepime, powder for solution for injection 500 mg and 1000 mg (Cefepime) | |||||
| Cefotaxime sodium, powder for solution for injection 500mg and 1000mg (Cefotaxim-natrium) | |||||
| Ceftriaxone, powder for solution for intravenous and intramuscular injection 500 mg and 1000 mg (Ceftriaxone ) | |||||
| Cilapenem, powder for solution for infusion 250mg/250mg or 500mg/500mg (Imipenem/Cilastatin) | |||||
| Meropenem, lyophilized powder for solution for injection 500 mg and 1000 mg (Meropenem) | |||||
| J01F – MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS | |||||
| Azitromycin, capsules 250 mg (Сapsulae Azithromycini 0,25) | |||||
| Lincomycin hydrochlorid, capsules 250 mg (Capsulae Lyncomycini hydrochloridi 0,25) | |||||
| Lincomycin hydrochlorid, solution for injection 30% - 1ml (Solutio Lyncomycini hydrochloridi 30% pro injectionibus) | |||||
| J01G – AMINOGLYCOSIDE ANTIBACTERIALS | |||||
| Gentamicin sulfate, solution for injection 4%- 2 ml (Solutio Gentamycini sulfatis 4% pro injectionibus) | |||||
| J01M – QUINOLONE ANTIBACTERIALS | |||||
| Cefepime, powder for solution for injection 500 mg and 1000 mg (Cefepime) | |||||
| Ciprofloxacin, solution for infusions 2mg.ml (Solutio Сiprofloxacini 0,3 % (guttae ophthalmicae)) | |||||
| Levofloxacin,solution for infusion 0,5%- 100 ml (Solutio Levofloxacini 0.5% pro infisio) | |||||
| J01X – OTHER ANTIBACTERIALS | |||||
| Linezolid, coated tablets 300mg, 600 mg (Linezolid) | |||||
| Linezolid, granules for oral suspension 100mg/5ml (Linezolid) | |||||
| Linezolid, solution for infusion 2 mg/ml (Linezolid) | |||||
| Metronidazole, solution for infusions 5 mg.ml (Metronidazole) | |||||
| Metronidazole, tablets 250 mg (Tabulettae Metronidazoli 0,25) | |||||
| Ornidazole, tablets 500 mg (Ornidazole) | |||||
| Vancomycin, lyophilized powder for solution infusion 1000 mg (Vancomycin) | |||||
| J02 – ANTIMYCOTICS FOR SYSTEMIC USE | |||||
| J02A - ANTIMYCOTICS FOR SYSTEMIC USE | |||||
| J04 – ANTIMYCOBACTERIALS | |||||
| J04A – DRUGS FOR TREATMENT OF TUBERCULOSIS | |||||
| Cycloserine, capsules 250 mg (Cycloserine.) | |||||
| PASK Sodium 12 g (Granulae natrii para-аminosalicylas.) | |||||
| PASK Sodium, powder for infusion 3 g - 100 ml (Natrii para-аminosalicylas 3.0g) | |||||
| Rifampicin, powder for injections 150 mg (Rifampicinum 0,15 pro injectionibus) | |||||
| J05 – ANTIVIRALS FOR SYSTEMIC USE | |||||
| J05A – DIRECT ACTING ANTIVIRALS | |||||
| Aciclovir lyophilized powder for solution for infusion 250mg, 500mg and 1000mg (Aciclovir 0,25, 0,5 et 1.0 g) | |||||
| Aciclovir-Belmed, tablets 200 mg, 400 mg (Tabulettae Acycloviri 0.2 et 0.4 g) | |||||
| Butaminophen ointment 2 % (Unguentum Вutaminopheni 2 %) | |||||
| Remantadine, tablets 50 mg №10 (Tabuletae Remantadini 0,05) | |||||
| Remantadine, tablets 50 mg № 20 (Tabuletae Remantadini 0,05) | |||||
| L – ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | |||||
| L01 – ANTINEOPLASTIC AGENTS | |||||
| L01A – ALKYLATING AGENTS | |||||
| Cyclophosphan, powder for preparing solution for injection 200 mg (Cyclophosphamide) | |||||
| Temobel, capsules 20 mg, 100 mg and 250 mg (Temozolomide) | |||||
| Temodex, powder for preparing gel for local use 100 mg (Temozolomide) | |||||
| L01B – ANTIMETABOLITES | |||||
| Ciprofloxacin, capsules 250 mg (ciprofloxacin) | |||||
| Cladribine, solution for injections 1 mg.ml (Cladribine) | |||||
| Cytarabine, lyophilized powder for solution for injection / solution for injection 20 mg/ml (Cytarabine - belmed) | |||||
| Cytarabine, lyophilized powder for solution for injections 1000 mg (Cytarabine - belmed) | |||||
| Fludarabine, lyophilized powder for solution for injection 50 mg (Fludarabine) | |||||
| Gemcitabine, lyophilized powder for solution for infusion 200 mg, 1000 mg (Gemcitabine) | |||||
| Leucladin, solution for injection 0.1%- 10 ml (Solutio Leucladini 0,1 % pro injectionibus) | |||||
| Mercaptopurine, tablets 50 mg (Mercaptopurine) | |||||
| Methotrexate, film-coated tablets 2.5 mg and 5 mg (Methotrexate) | |||||
| Methotrexate, lyophilized powder for solution for injection 10 mg, 50 mg, 1000 mg (Methotrexate) | |||||
| L01C – PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS | |||||
| Acetylcysteine, solution for inhalations 200mg/ml (Solutio Acetylcysteini 20 % pro ingalationis) | |||||
| Docetaxel, concentrate for preparing solution for infusion 20 mg/ml (Docetaxel) | |||||
| Paclitaxel, concentrate for solution for infusions 30 mg/5ml and 100mg/16.7ml (Paclitaxel) | |||||
| Vincristine, solution for injection 1 mg/2 ml (Vincristine) | |||||
| Vinorelbine, concentrate for solution for infusion 10 mg/ml (Vinorelbine) | |||||
| L01D – CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES | |||||
| Doxorubicin hydrochloride, lyophilized powder for solution for injection 10 mg (Doxorubicini hydrochloridum) | |||||
| L01X – OTHER ANTINEOPLASTIC AGENTS | |||||
| Fotolon, powder for injection 100 ml (Photolonum 0,1 pro injectionibus) | |||||
| Hydroxycarbamide, capsules 250 mg, 500mg (Hydroxycarbamide) | |||||
| Oxaliplatin, powder lyophilized for preparing solution for infusion 50 mg and 100 mg (Oxaliplatin) | |||||
| Photolon, lyophilized powder for solution for injection 100 mg (Sensitizers used in photodynamic/radiation therapy) | |||||
| L02 – ENDOCRINE THERAPY | |||||
| L02B - HORMOSNES AND RELATED AGENTS | |||||
| Anastrozole, coated tablets 1 mg (Anastrozole) | |||||
| L02A – HORMONES, AND RELATED AGENTS | |||||
| L03 – IMMUNOSTIMULANTS | |||||
| L03A – IMMUNOSTIMULANTS | |||||
| Sodium nucleinate, capsules 100 mg (Natrii nucleinas (capsules 0.1 g)) | |||||
| Thymalinum, powder for injection 10 mg (Thymalinum (lyophilized powder to prepare solution for injections)) | |||||
| M – MUSCULO-SKELETAL SYSTEM | |||||
| M01 – ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS | |||||
| M01A - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS | |||||
| Chondroitin sulfate capsules 0,25g №20 (Capsulae Chondroitini sulfatis) | |||||
| Diclofenac sodium, coated tablets 25 mg (Diclofenac) | |||||
| Diclofenac sodium, solution for injections 25 mg.ml. (Diclofenac) | |||||
| Diclofenac, coated tablets 25 mg (Tabulettar Diclophenac 0.025 obductae) | |||||
| Diclopentil 50 mg-100 mg tablets ("Diclopentil") | |||||
| Ibuprofen, coated tablets 200 mg (Tabulettae Ibuprofeni obductae 0.2) | |||||
| Mucosat, solution for injection (Mucosat (10% solution of chondroitin sulfate for injections)) | |||||
| M02 – TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN | |||||
| M02A – TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN | |||||
| Chondroart, ointment 15g (Unguentum «Chondroart») | |||||
| Chondroart, ointment 25g (Unguentum "Chondroart") | |||||
| Chondroxid, ointment 5% (Unguentum Chondroxidi 5 %) | |||||
| Dimexid, gel 25%- 40,0 g (Dimexidum) | |||||
| Dimexid, gel 50%- 40,0 g (Dimexidum) | |||||
| Ibuprophenum ointment 5%- 15 g (Unguentum Ibupropheni 5%) | |||||
| M03 – MUSCLE RELAXANTS | |||||
| M03A – MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS | |||||
| Dithilin, solution for injection 2%- 5 ml (Solutio Dithilini 2% pro injectionibus) | |||||
| M05 – DRUGS FOR TREATMENT OF BONE DISEASES | |||||
| M05B – DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION | |||||
| Zoledronic acid, lyophilized powder for solution for infusion 4 mg (Zolendronic acid) | |||||
| N – NERVOUS SYSTEM | |||||
| N01 – ANESTHETICS | |||||
| N01B – ANESTHETICS, LOCAL | |||||
| Lidocaine hydrochloride, solution for injection 2%- 2 ml (Solutio Lidocaini hydrochloridi 2% pro injectionibus) | |||||
| N02 – ANALGETICS | |||||
| N02A – OPIOIDS | |||||
| Butorphanol tartrate, solution fot injection 0,2%-1 ml (Solutio Butorphanoli tartratis 0,2 % pro injectionibus) | |||||
| Fentanyl, solution for injections 0,005%- 2 ml (Solutio Phentanyli pro injectionibus 0.005%) | |||||
| Morphine hydrochloride, solution for injections 10 mg.ml (Morphine.) | |||||
| Morphine, capsules 40 mg (Solutio Morphini hydrochloride 1% et 5% pro injectionibus) | |||||
| Promedol, solution for injections 2%- 1 ml (Solutio Promedoli 2% pro injectionibus) | |||||
| N02B – OTHER ANALGETICS AND ANTIPYRETICS | |||||
| Analgin, tablets 500 mg (Tabulettae Analgini 0,5) | |||||
| Grostudin, powder for oral solution (Grostudin) | |||||
| Parascophen, tablets № 10 (Parascophen) | |||||
| Pentalgin-N, tablets № 10 (Pentalgin) | |||||
| Pentalgin-N, tablets № 20 (Pentalgin) | |||||
| N03 – ANTIEPILEPTICS | |||||
| N03A – ANTIEPILEPTICS | |||||
| Phenobarbital tablets 0.1 g (Tabulettae Phenobarbitali 0.1) | |||||
| N05 – PSYCHOLEPTICS | |||||
| N05A – ANTIPSYCHOTICS | |||||
| Dropperidol, solution for injection 0,25%- 5 ml (Solutio Droperidoli 0.25% pro injectionibus) | |||||
| N05B – ANXIOLYTICS | |||||
| Phenibut, tablets 250 mg (Tabulletae Phenibuti 0.25)) | |||||
| N05C – HYPNOTICS AND SEDATIVES | |||||
| Valeriana-Belmed, coated tablets 200 mg (Tabulettae Valerianae 0,1 et 0,2 оbductae) | |||||
| N06 – PSYCHOANALEPTICS | |||||
| N06A - ANTIDEPRESSANTS | |||||
| N06B – PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS | |||||
| Cerebrolysat, solution for injection 1ml (Cerebrolysatum) | |||||
| Piracetam, capsules 400 mg (Capsulae Piracetami 0,4) | |||||
| Piracetam, coated tablets 400 mg (Piracetam.) | |||||
| Piracetam, solution for injections 20 % - 5 ml (Solutio Piacetami pro injectionibus 20%) | |||||
| N07 – OTHER NERVOUS SYSTEM DRUGS | |||||
| N07X – OTHER NERVOUS SYSTEM DRUGS | |||||
| Emoxipine, solution for infusion 0,5%-100 ml (Solutio Emoxipini 0,5 % pro infusion) | |||||
| Emoxipine-Belmed, solution for injections 10 mg.ml and 30 mg (Solutio Emoxipini 1 % et 3 % pro injectionibus) | |||||
| Mexibel, solution for infusionn 0,2 % 100 ml (Mexibel) | |||||
| Mexibel, solution for injection 5 % - 2 ml № 10 (Mexibel) | |||||
| P – ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS | |||||
| P01 – ANTIPROTOZOALS | |||||
| P01A – AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES | |||||
| P01AB – NITROIMIDAZOLE DERIVATIVES | |||||
| Ornidazole, tablets 500 mg (Ornidazole) | |||||
| R – RESPIRATORY SYSTEM | |||||
| R01 – NASAL PREPARATIONS | |||||
| R01A – DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE | |||||
| Naphtizine, nasal drops 1 mg.ml (Naphazolinum.) | |||||
| R02 – THROAT PREPARATIONS | |||||
| R02A – THROAT PREPARATIONS | |||||
| R05 – COUGH AND COLD PREPARATIONS | |||||
| R05C – EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS | |||||
| Acetylcysteine, solution for inhalations 200mg/ml (Solutio Acetylcysteini 20 % pro ingalationis) | |||||
| Mucosol, syrup 80 ml (Mucosol) | |||||
| R06 – ANTIHISTAMINES FOR SYSTEMIC USE | |||||
| R06A – ANTIHISTAMINES FOR SYSTEMIC USE | |||||
| Dimedrol, solution for injection 1%-1 ml (Solutio Dimedroli 1% pro injectionibus) | |||||
| Dimedrol, tablets 50 mg (Tabulettae Dimedroli 0.05) | |||||
| Ketotifen, tablets 1 mg (Ketotifen) | |||||
| Loratodine, tablets 10 mg (Loratadine) | |||||
| S – SENSORY ORGANS | |||||
| S01 – OPHTHALMOLOGICALS | |||||
| S01A – ANTIINFECTIVES | |||||
| Ciprofloxacin, eye drops 0,3%- 5 ml (Solutio Сiprofloxacini 0,3 % (guttae ophthalmicae)) | |||||
| Gentamicin, eye drops 0,3%- 1ml in tube-dropping glass (Solutio Gentamicini sulfatis 0,3% (guttae ophthalmicae)) | |||||
| Gentamycin sulfate (solution 0.3% (eye drops)) (Solutio Gentamicini sulfatis 0.3% (guttae ophthalmicae)) | |||||
| Levofloxacin, eye drops 5mg.ml (Levofloxacin) | |||||
| Levomycetin, eye drops 0.25%- 10 ml (Solutio Laevomycetini 0,25% (guttae ophthalmicae)) | |||||
| Nucleavir, ophthalmic ointment 3,0 g (Unguentum Nucleavir ophtalmicum) | |||||
| Nucleavir, ophthalmic ointment 5,0 g (Unguentum Nucleavir ophtalmicum) | |||||
| Sulfacyl sodium, eye drops 20 % - 5 ml (Solutio Sulfacyli natrii 20% (guttae ophthalmicae)) | |||||
| Sulfacyl sodium, eye drops 20 % in tube-dropping glass 1 ml (Solutio Sulfacyli natrii 20% (guttae ophthalmicae)) | |||||
| Sulfacyl sodium, eye drops 30 % - 5 % ml (Solution Sulfacyli natrii 30% (guttae ophthalmicae)) | |||||
| Zinc sulfate 2.5 mg.ml and Boric acid 20 mg.ml, eye drops (zinc sulphate 0.25% and boric acid 2%) | |||||
| S01B – ANTIINFLAMMATORY AGENTS | |||||
| Dexamethasone, eye drops 0,1%-5ml (Dexamethasone) | |||||
| Diclofenac, eye drops 1mg.ml (Diclofenac) | |||||
| Diclofenac, eye drops 1mg.ml (Diclofenac) | |||||
| S01C – ANTINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION | |||||
| Gentadex, eye drops (1mg.3mg).1ml (Gentadex) | |||||
| S01E – ANTIGLAUCOMA PREPARATIONS AND MIOTICS | |||||
| Pilocarpine hydrochloride, eye drops 1 % - 1 ml № 10 in tube-dropping glass (Solutio Pilocarpini hydrochloridi 1% (guttae ophthalmicae)) | |||||
| Proxodolol, eye drops 1% - 1 ml № 10 in tube-dropping glass (Proxodololum) | |||||
| Timolol, eye drops 0,25% - 1 ml № 2 in tube-dropping glass (Timolol) | |||||
| Timolol, eye drops 0,5% - 1 ml № 2 in tube-dropping glass (Timolol 0.25% and 0.5% (eye drops)) | |||||
| Timolol, eye drops 0,5% - 5 ml (Timolol) | |||||
| S01X – OTHER OPHTHALMOLOGICALS | |||||
| Emoxipin, eye drops 1%- 5 ml (Solutio Emoxipini 1 % pro injectionibus) | |||||
| Sevitin, eye drops-nasal drops 5 ml (Solutio Сarnosini 5%) | |||||
| Sevitin, eye drops-nasal drops №2 (Solutio Сarnosini 5%) | |||||
| Taufon, eye drops 4 % - 5 ml (Taufonum (guttae ophthalmicae)) | |||||
| Vitaden, eye drops 1 ml № 2 in tube-dropping glass (Solutio "Vitadenum", guttae ophtalmicae) | |||||
| V – VARIOUS | |||||
| V03 – ALL OTHER THERAPEUTIC PRODUCTS | |||||
| V03A - ALL OTHER THERAPEUTIC PRODUCTS | |||||
| Calcium folinate, lyophilized powder for solution for injections 50 mg and 100 mg (Calcium folinate) | |||||
| Unithiol, solution for injection 5% - 5 ml (Solutio unithioli 5% pro injectionibus) | |||||
| V07 –ALL OTHER NON-THERAPEUTIC PRODUCTS | |||||
| V07A –ALL OTHER NON-THERAPEUTIC PRODUCTS | |||||
